March 10, 2025
Recent research indicates that GLP-1 drugs like Ozempic, initially approved for diabetes and weight loss, may offer additional health benefits. These include potential protective effects against age-related conditions such as Alzheimer’s disease, osteoarthritis, certain cancers, and overall mortality.
To read full article, visit: Ozempic’s New Frontier: The War on Aging – WSJ
We use cookies to improve your browsing experience, analyze website traffic, and personalize content. By clicking “Accept All” you consent to our use of cookies. You can manage your preferences at any time. See our Privacy Policy.
We use cookies to run this site and, with your permission, to analyze traffic and personalize content. Choose which cookies to allow. See our Privacy Policy.
Required for the website to work. Always active.
Lets us measure website traffic and personalize content through Google Analytics. Nothing loads until you allow it.